Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 20, 2012
- Accepted for publication May 21, 2012
- Published online July 27, 2012.
Article Versions
- Latest version (June 7, 2012 - 08:12).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 The American Association for Clinical Chemistry
Author Information
- Jason S. Troutt1,
- Mats Rudling2,3,4,
- Lena Persson2,3,4,
- Lars Ståhle5,
- Bo Angelin2,3,4,
- Anthony M. Butterfield1,
- Andrew E. Schade1,
- Guoqing Cao1 and
- Robert J. Konrad1,*
- 1 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN;
- 2 Metabolism Unit, Department of Endocrinology, Metabolism and Diabetes, and
- 3 Department of Medicine, Karolinska Institute at Karolinska University Hospital at Huddinge, Stockholm, Sweden;
- 4 Molecular Nutrition Unit, Department of Bioscience and Nutrition, and
- 5 Department of Clinical Pharmacology, Karolinska Institute at Karolinska University Hospital at Huddinge, Stockholm, Sweden.
- ↵* Address correspondence to this author at: Eli Lilly and Company, Indianapolis, IN 46285. Fax 317-276-5281; e-mail konrad_robert{at}lilly.com.
Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration
